Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos

• Published in: Genes & development 2013-09, Vol.27 (18), p.1959-1973
• Main Authors: Briso, Eva M, Guinea-Viniegra, Juan, Bakiri, Latifa, Rogon, Zbigniew, Petzelbauer, Peter, Eils, Roland, Wolf, Ronald, Rincón, Mercedes, Angel, Peter, Wagner, Erwin F
• Format: Article
• Language: English
• Subjects: Animals; Benz(a)Anthracenes; Carcinoma, Squamous Cell - physiopathology; CD4-Positive T-Lymphocytes - cytology; Cell Line, Tumor; Cell Transformation, Neoplastic - genetics; Cell Transformation, Neoplastic - metabolism; Epidermis - metabolism; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hyperplasia - genetics; Hyperplasia - metabolism; Hyperplasia - physiopathology; Inflammation; Male; Matrix Metalloproteinase 10 - genetics; Matrix Metalloproteinase 10 - metabolism; Mice; Papilloma - chemically induced; Papilloma - pathology; Proto-Oncogene Proteins c-fos - genetics; Proto-Oncogene Proteins c-fos - metabolism; Research Paper; Signal Transduction; Skin Neoplasms - physiopathology
• ISSN: 0890-9369; 1549-5477
• DOI: 10.1101/gad.223339.113

Skin squamous cell carcinomas (SCCs) are the second most prevalent skin cancers. Chronic skin inflammation has been associated with the development of SCCs, but the contribution of skin inflammation to SCC development remains largely unknown. In this study, we demonstrate that inducible expression of c-fos in the epidermis of adult mice is sufficient to promote inflammation-mediated epidermal hyperplasia, leading to the development of preneoplastic lesions. Interestingly, c-Fos transcriptionally controls mmp10 and s100a7a15 expression in keratinocytes, subsequently leading to CD4 T-cell recruitment to the skin, thereby promoting epidermal hyperplasia that is likely induced by CD4 T-cell-derived IL-22. Combining inducible c-fos expression in the epidermis with a single dose of the carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) leads to the development of highly invasive SCCs, which are prevented by using the anti-inflammatory drug sulindac. Moreover, human SCCs display a correlation between c-FOS expression and elevated levels of MMP10 and S100A15 proteins as well as CD4 T-cell infiltration. Our studies demonstrate a bidirectional cross-talk between premalignant keratinocytes and infiltrating CD4 T cells in SCC development. Therefore, targeting inflammation along with the newly identified targets, such as MMP10 and S100A15, represents promising therapeutic strategies to treat SCCs.